Quick Answer
CorMedix Inc. reported Stockholders Equity of $405.31 million for fiscal year 2025.
CorMedix Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $405.31M | +378.8% |
| 2024 | $84.66M | +20.7% |
| 2023 | $70.14M | +27.4% |
| 2022 | $55.06M | -12.3% |
| 2021 | $62.80M | +42.0% |
| 2020 | $44.22M | +87.0% |
| 2019 | $23.65M | +379.2% |
| 2018 | $4.93M | -31.4% |
| 2017 | $7.19M | -59.6% |
| 2016 | $17.81M | -47.6% |
| 2015 | $34.01M | +835.8% |
| 2014 | $3.63M | +190.4% |
| 2013 | -$4.02M | -1099.4% |
| 2012 | -$335.4K | -127.1% |
| 2011 | $1.24M | -83.0% |
| 2010 | $7.26M | +149.3% |
| 2009 | -$14.71M | -22.3% |
| 2008 | -$12.03M | -173.6% |
| 2007 | -$4.40M | -355.0% |
| 2006 | -$966.2K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $374.13M | +537.2% | +69.6% |
| June 30, 2025 | $220.63M | +377.7% | +92.0% |
| March 31, 2025 | $114.89M | +98.0% | +35.7% |
| December 31, 2024 | $84.66M | +20.7% | +44.2% |
| September 30, 2024 | $58.71M | -29.4% | +27.1% |
| June 30, 2024 | $46.18M | -5.8% | -20.4% |
| March 31, 2024 | $58.01M | +7.6% | -17.3% |
| December 31, 2023 | $70.14M | +27.4% | -15.7% |
- CorMedix Inc. showed an increase of +378.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2006–2025 period, CorMedix Inc.’s stockholders equity has grown by 42049.9% (from -$966.2 thousand to $405.31 million).
- The most recent figure is from CorMedix Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: